Oppenheimer analysts downgraded Pliant Therapeutics stock from Outperform to Perform, following a significant development ...

Parex Resources expanded its joint venture with Ecopetrol. Learn more about PARXF stock here and why it is rated as Strong ...

Funds to be used primarily to advance development of ATH434 in Parkinsonian Disorders –– Capital raising was strongly supported by domestic and ...

Akebia Therapeutics is currently shifting focus from Auryxia to Vafseo due to Auryxia’s declining revenues. See why I ...

John Marshall Bancorp, Inc. (Nasdaq: JMSB) (the "Company"), parent company of John Marshall Bank (the "Bank"), reported net income of $4.8 million ($0.33 per diluted common share) for the quarter ...

Market uncertainty makes investors nervous about investing in speculative industries. But Wall Street has high hopes for ...

H.C. Wainwright downgraded Pliant Therapeutics (NASDAQ:PLRX) stock from Buy to Neutral following concerns about the safety of ...

Much like the Title IX fact sheet issued by the DOE, this statement of interest is not law. While the DOJ raises compelling ...

As a condition for the loan, Entero replaced three of five members of its Board of Directors with three new directors designated by the lender. These appointments follow the resignations of James ...

The company's CEO said nonprofit organizations will need to spend even more time managing their dollars in the wake of a new ...

Quince also offers a yearlong trial to decide if you ... the Sijo AiryWeight Eucalyptus Sheet Set is refreshingly soft and strikes the right balance of comfort, coolness, durability, and price.

The bottom line is few companies can match its combination of established leadership in rare diseases and realistic pathways to significant market expansion, making Vertex stock a worthwhile buy in ...